Parametric Portfolio Associates’s Metacrine, Inc. Common Stock MTCR Stock Holding History
Bought
Maintained
Sold
Other funds holding MTCR
NMC
VP
PM
AG
ACH
DM
Parametric Portfolio Associates's MTCR Position: Q3 2021 in Review
Parametric Portfolio Associates sold out of Metacrine, Inc. Common Stock (MTCR) in Q3 2021, closing a stake of 55,753 shares — an estimated $212K sold.
Parametric Portfolio Associates first reported a position in MTCR in Q3 2020 and held it in 4 quarters. The position peaked at $584K in Q1 2021. 35 funds tracked by Wall St. Rank hold MTCR as of Q3 2021.
- Parametric Portfolio Associates reported no remaining Metacrine, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
- Parametric Portfolio Associates sold 55,753 Metacrine, Inc. Common Stock shares in Q3 2021, an estimated $212K.
- Parametric Portfolio Associates first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
- Parametric Portfolio Associates's Metacrine, Inc. Common Stock position peaked at $584K in Q1 2021.
- 35 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q3 2021.
Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.